Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,944.00
(
0.88%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
-2.31%
)
Bitcoin
78,160.49
(
2.40%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122925
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Tuesday, 01/08/2008 8:13:18 PM

Tuesday, January 08, 2008 8:13:18 PM

Post# of 3757
IDIX 2008 Goals

[As stated on JPM webcast 8-Jan-2008.]

HIV

--Complete phase-2a IDX899 7-day monotherapy study (in progress); report results at CROI conference in February.

--Start phase-2 IDX899 6-week combination study.

--Partner IDX899 program following phase-2 study.

HCV

--File IND for IDX184 and complete phase-1 trial.

--Start phase-2a study for IDX184 in combination with HCV SoC.

--File IND for HCV protease inhibitor and complete phase-1 trial.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote